VerifyMe Technologies to Combat World-Wide Counterfeit Drug Epidemic

▴ VerifyMe Technologies to Combat World-Wide Counterfeit Drug Epidemic
VerifyMe and Techind will work together in providing the VeriPAS(TM) serialization

VerifyMe, Inc., a digital technology solutions provider specializing in counterfeit prevention, authentication, serialization, data mining, track and trace, features for labels, packaging and products, is pleased to announce that it has entered into a strategic relationship with Techind Engineers & Consultants-Impex, part of the Gohar Group, of India.

Techind has experience in serialization and track and trace, having sold and installed more than 100 production line serialization systems for 10 clients in the Pharmaceutical industry over the past few years.

VerifyMe and Techind will work together in providing the VeriPAS(TM) serialization and track and trace solution to the broad range of industries and clients of Techind, with specific focus on the Pharmaceutical industry. Other project areas of Techind include: Bio-technology, Processed Food, Chemicals and Allied Packaging up to tertiary stage, on a turnkey basis. With 35+ years of presence in the market, Techind has earned its position, trust and goodwill in the region.

Techind's CEO A.J.S Gohar stated, "We have experience in serialization and track and trace over the past 9 years as our clients have asked for product authentication and brand protection solutions. VerifyMe's VeriPAS is an upgrade from what we were previously doing and something we believe our existing clients can integrate with and new clients will desire. We have already highlighted the areas of pharmaceutical, nutraceutical and consumer products, where we have clients and relationships that seek serialization and track and trace solutions. This partnership is particularly timely given our experience in the pharma industry and recent avenues to serialize and authenticate COVID-19 test kits. This will be an immediate area of focus. We look forward to rolling out VeriPAS to our client base in India, the SAARC region, and worldwide."

VerifyMe Chief Executive Officer Patrick White commented, "According to the World Health Organization, people are dying in the tens of thousands from the scourge of counterfeit drugs.People want comfort that the drugs and medications they are taking are authentic. Our technologies allow both users and brand inspectors to perform a simple instant effective authentication test with their smart phone. We are thrilled to have our technologies chosen by the Gohar Group and Techind. Combining our counterfeit protection technologies with their expertise in building pharmaceutical manufacturing systems is a win not only for their pharmaceutical clients but for the people that need to be protected from harmful and deadly counterfeit drugs. Their business success and impeccable reputation, not only in India and the SAARC region, but worldwide, represent an opportunity for our serialization and track and trace solution, VeriPAS. Their client list is extremely impressive and particularly in pharma, represents great opportunity for us potentially with the likes of Sun Pharma, Cipla, Lupin, Panacea Biotec, Wockhardt, Intas, Apotex, Hospira, Johnson & Johnson, Daiichi Sankyo, Sanofi Aventis, Glaxo Smithkline, Novartis, Merck, Pfizer and AstraZeneca. We also look forward to working with Mr. Adhinayak Gohar - Director Technical of Techind in making our world a safer place."

Tags : #VerifyMe #Epidemic #Techind

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024